Actively Recruiting

Age: 0Minutes +
All Genders
NCT07278375

Target Trial Emulation for Pharmacologic Treatment of Neonatal Opioid Withdrawal Syndrome

Led by HELP for NOWS Consortium · Updated on 2026-02-25

796

Participants Needed

22

Research Sites

37 weeks

Total Duration

On this page

Sponsors

H

HELP for NOWS Consortium

Lead Sponsor

E

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Collaborating Sponsor

AI-Summary

What this Trial Is About

The goal of this observational study is to learn how two medicines used in routine care-buprenorphine and morphine-affect recovery in newborns (≥36 weeks' gestation) with Neonatal Opioid Withdrawal Syndrome (NOWS). The main questions it aims to answer are: 1. Do infants treated with buprenorphine become medically ready for discharge sooner than those treated with morphine? 2. Does one treatment lead to better overall clinical outcomes than the other? Researchers will compare infants who received buprenorphine with infants who received morphine to see whether one treatment helps babies recover more quickly. Participants will not be asked to do anything. Instead, the study team will collect information already documented in the infant's and mother's medical records securely without any contact or changes to clinical care. No new medicines, procedures, or visits are involved. This study only reviews existing clinical data to better understand which commonly used treatment may support faster recovery for newborns with NOWS.

CONDITIONS

Official Title

Target Trial Emulation for Pharmacologic Treatment of Neonatal Opioid Withdrawal Syndrome

Who Can Participate

Age: 0Minutes +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Infant is at least 36 weeks' gestational age
  • Infant had opioid exposure before birth confirmed by maternal history or toxicology during pregnancy or infant toxicology during hospital stay
  • Infant is being assessed and managed for NOWS at a study site
  • Infant is at risk for pharmacologic treatment for NOWS based on scoring tools
  • Infant met all inclusion criteria on or after March 25, 2024
Not Eligible

You will not qualify if you...

  • Infant has major congenital anomalies
  • Infant has neonatal encephalopathy, metabolic disorder, stroke, intracranial hemorrhage, or meningitis before treatment
  • Infant is receiving respiratory support at 48 hours of age
  • Infant had major surgery before or at 48 hours of age
  • Infant had opioid exposure after birth before starting treatment
  • Infant was born outside and started treatment at a different hospital

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 22 locations

1

University of Alabama at Birmingham

Birmingham, Alabama, United States, 35294

Actively Recruiting

2

University of Arkansas for Medical Sciences

Little Rock, Arkansas, United States, 72205-7199

Actively Recruiting

3

ChristianaCare

Wilmington, Delaware, United States, 19801

Not Yet Recruiting

4

University of South Florida Health

Tampa, Florida, United States, 33606

Actively Recruiting

5

Riley Hospital for Children at IU Health

Indianapolis, Indiana, United States, 46202-5119

Actively Recruiting

6

Sidney & Lois Eskenazi Hospital

Indianapolis, Indiana, United States, 46202

Actively Recruiting

7

University of Louisville Hospital

Jeffersonville, Indiana, United States, 47130

Not Yet Recruiting

8

St. Elizabeth Healthcare

Edgewood, Kentucky, United States, 41017

Not Yet Recruiting

9

Kentucky Children's Hospital

Lexington, Kentucky, United States, 40536

Actively Recruiting

10

Norton Children's Hospital

Louisville, Kentucky, United States, 40202

Not Yet Recruiting

11

Norton Women's and Children's Hospital

Louisville, Kentucky, United States, 40207

Not Yet Recruiting

12

Children's Regional Hospital, Cooper University Health Care

Camden, New Jersey, United States, 08103

Not Yet Recruiting

13

University of New Mexico Health Sciences Center

Albuquerque, New Mexico, United States, 87131

Actively Recruiting

14

University of Rochester Medical Center

Rochester, New York, United States, 14642

Not Yet Recruiting

15

Good Samaritan Hospital

Cincinnati, Ohio, United States, 45202

Not Yet Recruiting

16

Cincinnati Children's Hospital Medical Center

Cincinnati, Ohio, United States, 45229

Not Yet Recruiting

17

Rainbow Babies and Children's Hospital

Cleveland, Ohio, United States, 44106

Not Yet Recruiting

18

Children's Hospital of Philadelphia

Philadelphia, Pennsylvania, United States, 19104

Actively Recruiting

19

Pennsylvania Hospital

Philadelphia, Pennsylvania, United States, 19107

Not Yet Recruiting

20

Thomas Jefferson University Hospital

Philadelphia, Pennsylvania, United States, 19107

Actively Recruiting

21

University of Utah Health

Salt Lake City, Utah, United States, 84158

Not Yet Recruiting

22

University of Vermont Medical Center

Burlington, Vermont, United States, 05401

Not Yet Recruiting

Loading map...

Research Team

W

Walter K Kraft, MD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here